My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

115.11 -4.07 (-3.42%)

Streaming Delayed Price Updated: 3:37 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Down More Than 50% Since July, This Incredible Growth Stock Is a Screaming Buy on the Dip ↗

October 14, 2023

TransMedics Group's stock price is lower now than it was before it became an indispensable part of the organ transplant process.

Via The Motley Fool

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 11, 2023

Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...

Via Benzinga

Why Shares of TransMedics Group Are Falling Friday ↗

August 04, 2023

The company released second-quarter earnings.

Via The Motley Fool

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Analyst Ratings for TransMedics Gr ↗

May 18, 2023

Via Benzinga

TransMedics Group Inc. (NASDAQ: TMDX) is a Stock Spotlight on 5/12

May 12, 2023

Via Investor Brand Network

Checking In on the Fed, FedEx, and TransMedics ↗

September 28, 2023

There's a lot for investors to pay attention to.

Via The Motley Fool

Topics Economy

3 Best Stocks to Buy With $300 Right Now ↗

September 28, 2023

Whether driven by unstoppable megatrends or wide moats, these three stocks are poised to continue growing.

Via The Motley Fool

Jim Cramer Says 'Entertainment Stocks Are So Hated': Here's One That's 'Not Expensive Anymore' ↗

September 27, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Devon Energy Corporation’s (NYSE: DVN) stock is "low enough, it had a bad quarter, it’s being punished

Via Benzinga

Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains ↗

September 13, 2023

Unearth the three best healthcare stocks to buy that are poised for long-term growth ahead for savvy investors.

Via InvestorPlace

The 3 Most Promising Healthcare Stocks to Own Now ↗

September 01, 2023

These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.

Via InvestorPlace

TransMedics Group Inc. (NASDAQ: TMDX) is a Stock Spotlight on 4/28

April 28, 2023

Via Investor Brand Network

TransMedics Gr Earnings Preview ↗

April 28, 2023

Via Benzinga

3 Top Growth Stocks to Buy Right Now ↗

August 29, 2023

Their prices have dipped in the last month, but the long-term outlooks for these stocks remain strong.

Via The Motley Fool

2 Unstoppable Growth Stocks You Can Buy With $200 Right Now ↗

August 06, 2023

Even a modest investment in these stocks could lead to significant gains for patient investors.

Via The Motley Fool

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review ↗

August 04, 2023

Amazon, ELF and CAT were earnings winners, but there were big losers too.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 04, 2023

Via Benzinga

Why BigCommerce Holdings Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket ↗

August 04, 2023

Gainers Tupperware Brands Corporation (NYSE: TUP) shares surged 53.3% to $5.40 in pre-market trading after the company announced a debt restructuring agreement.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

August 04, 2023

It's time to start the day final of trading this week with an overview of the biggest pre-market stock movers on Friday morning!

Via InvestorPlace

Apple, Fortinet, Microchip Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

August 04, 2023

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 03, 2023

Via Benzinga

TransMedics Revolutionizing Global Organ Transplant Market: Analyst Initiates With Buy Rating ↗

July 19, 2023

William Blair initiated coverage on TransMedics Group Inc (NASDAQ: TMDX) with an Outperfo

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023 ↗

July 19, 2023

Via Benzinga

Healthcare Technology: 3 Companies to Keep an Eye On Now ↗

June 15, 2023

Healthcare technology stocks have generated high returns in the past and are likely to do so going forward as well.

Via InvestorPlace

The Good News From Chewy, Five Below, MongoDB, and Lululemon ↗

June 10, 2023

Plus, some talk about why Compass Minerals and Veeva Systems deserve a closer look.

Via The Motley Fool

Is TransMedics Group Stock a Buy on the Dip? ↗

May 05, 2023

Shares of this high-flying healthcare stock stumbled recently despite an outstanding performance in the first few months of 2023.

Via The Motley Fool

TransMedics Group Inc. (NASDAQ: TMDX) Making Surprising Moves in Friday Session

April 21, 2023

Via Investor Brand Network

Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait 10 Years ↗

March 21, 2023

Patient investors who would like to see their investments rise 10x have some interesting options right now.

Via The Motley Fool

Earnings Scheduled For May 1, 2023 ↗

May 01, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.